Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L MICHAUX

Showing results (61-70 of 230) with videos related to

Pageof 23
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1979
Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinomaA Ferrant, R Hulhoven, A Bosly, et al.
Acta Clinica Belgica|December 27, 2014
Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?P Biller, L Michaux, L De Pauw, et al.
Acta Clinica Belgica|April 8, 1999
[Is there a link between secondary hemochromatosis and genetics? Apropos of 2 cases]I Paris, K Dahan, M van Ypersele, et al.
Journal of Computer Assisted Tomography|September 1, 1993
Apparent focal bone marrow ischemia in patients with marrow disorders: MR studiesB Vande Berg, J Malghem, M A Labaisse, et al.
Bone Marrow Transplantation|January 1, 1989
Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantationP Borgies, A Ferrant, A Delannoy, et al.
Scandinavian Journal of Haematology|July 1, 1980
Selective hypoplasia of pelvic bone marrowA Ferrant, J Rodhain, A Cordier, et al.
Bone Marrow Transplantation|February 1, 1997
Additional myeloablation with 52Fe before bone marrow transplantationC Jacquy, A Ferrant, N Leners, et al.
Cancer Genetics and Cytogenetics|April 1, 1988
The short arm of chromosome 6 is nonrandomly rearranged in secondary myelodysplastic syndromesC Mecucci, J L Michaux, A Louwagie, et al.
British Journal of Haematology|April 1, 1982
Assessment of the sites of red cell destruction using quantitative measurements of splenic and hepatic red cell destructionA Ferrant, F Cauwe, J L Michaux, et al.
Leukemia|February 13, 2009
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenibE Lierman, L Michaux, E Beullens, et al.
Pageof 23

Showing results (61-70 of 230) with videos related to

Sort By:
Pageof 23
Cancer Chemotherapy and Pharmacology|January 1, 1979
Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinomaA Ferrant, R Hulhoven, A Bosly, et al.
Acta Clinica Belgica|December 27, 2014
Post-transplant lymphoproliferative disorder after kidney transplantation: time to adopt monitoring of Epstein-Barr virus?P Biller, L Michaux, L De Pauw, et al.
Acta Clinica Belgica|April 8, 1999
[Is there a link between secondary hemochromatosis and genetics? Apropos of 2 cases]I Paris, K Dahan, M van Ypersele, et al.
Journal of Computer Assisted Tomography|September 1, 1993
Apparent focal bone marrow ischemia in patients with marrow disorders: MR studiesB Vande Berg, J Malghem, M A Labaisse, et al.
Bone Marrow Transplantation|January 1, 1989
Interferon alpha induced and maintained complete remission in chronic granulocytic leukemia in relapse after bone marrow transplantationP Borgies, A Ferrant, A Delannoy, et al.
Scandinavian Journal of Haematology|July 1, 1980
Selective hypoplasia of pelvic bone marrowA Ferrant, J Rodhain, A Cordier, et al.
Bone Marrow Transplantation|February 1, 1997
Additional myeloablation with 52Fe before bone marrow transplantationC Jacquy, A Ferrant, N Leners, et al.
Cancer Genetics and Cytogenetics|April 1, 1988
The short arm of chromosome 6 is nonrandomly rearranged in secondary myelodysplastic syndromesC Mecucci, J L Michaux, A Louwagie, et al.
British Journal of Haematology|April 1, 1982
Assessment of the sites of red cell destruction using quantitative measurements of splenic and hepatic red cell destructionA Ferrant, F Cauwe, J L Michaux, et al.
Leukemia|February 13, 2009
FIP1L1-PDGFRalpha D842V, a novel panresistant mutant, emerging after treatment of FIP1L1-PDGFRalpha T674I eosinophilic leukemia with single agent sorafenibE Lierman, L Michaux, E Beullens, et al.
Pageof 23